HIM
APLS

Hillhouse Investment Management’s Apellis Pharmaceuticals APLS Stock Holding History

Hillhouse Investment Management’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$53.2M Hold
2,098,581
– – 1.7% 14
2019
Q1 		$40.9M Hold
2,098,581
– – 1.71% 13
2018
Q4 		$27.7M Sell
2,098,581
-2,229,708
-52% -$34.2M 2.07% 8
2018
Q3 		$77M Hold
4,328,289
– – 2.06% 10
2018
Q2 		$95.2M Buy
4,328,289
+2,899,718
+203% +$66.6M 1.62% 15
2018
Q1 		$31.6M Hold
1,428,571
– – 0.56% 25
2017
Q4 		$31M Buy
+1,428,571
New +$21M 0.53% 20

Other funds holding APLS

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return

Hillhouse Investment Management's APLS Position: Q2 2019 in Review

Hillhouse Investment Management held its Apellis Pharmaceuticals (APLS) position steady in Q2 2019 at 2,098,581 shares worth $53.2M. The position accounts for 1.7% of the portfolio, ranked #14.

Hillhouse Investment Management first reported a position in APLS in Q4 2017 and has held it in 7 quarters since. The position peaked at $95.2M in Q2 2018. 99 funds tracked by Wall St. Rank hold APLS as of Q2 2019.

  • Hillhouse Investment Management held 2,098,581 shares of Apellis Pharmaceuticals worth $53.2M as of Q2 2019.
  • Hillhouse Investment Management left its Apellis Pharmaceuticals share count unchanged in Q2 2019.
  • Apellis Pharmaceuticals made up 1.7% of Hillhouse Investment Management's portfolio in Q2 2019, its #14 holding.
  • Hillhouse Investment Management first reported a position in Apellis Pharmaceuticals in Q4 2017 and has held it in 7 quarters since.
  • Hillhouse Investment Management's Apellis Pharmaceuticals position peaked at $95.2M in Q2 2018.
  • 99 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2019.

Based on Hillhouse Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.